RHYTHM PHARMACEUTICALS INC stock forecast: up to 22.36 USD RYTM stock price prognosis


Forecast for Fri 17 Nov 2023 price 21.75

RHYTHM PHARMACEUTICALS INC stock price forecast for further price development up to 23.06% (time horizon: 1 day) and price target of 22.36 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) RHYTHM PHARMACEUTICALS INC share price prediction for 2023-11-17 with daily closed price projections

Key Facts

Symbol RYTM 

ISIN US76243J1051 

CUSIP 76243J105

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (0.90)

News <--> Close correlation for next day influence (-0.25)

Finance numbers

Revenue 35,000.0

Earnings per share -1.36

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

No patients with Alström syndrome met the primary endpoint. Patient identification is a core focus of our cross-functional teams. We are studying Alström syndrome patients who are severely obese. This gives rise to a well-documented form of severe early-onset obesity and hyperphagia. Most often these symptoms were reported in the first week of treatment. IMCIVREE is approved in the US for patients 6 years of age and older. In this event, the NDA must be resubmitted with the additional information. The IVDR will become applicable on 26 May 2022. The purpose of the bill is to enable the existing UK regulatory frameworks to be updated. As a result, increasingly high barriers are being erected to the entry of new products. However, this consequence cannot be excluded. These changes will lead to additional costs and increase our overall risk exposure. The FDA may designate drugs for relatively small patient populations as orphan drugs. In addition, new products developed by others could emerge as competitors to IMCIVREE. Patents, if issued, may be challenged, deemed unenforceable, invalidated or circumvented. Patent litigation is costly and time consuming. We may not have sufficient resources to bring these actions to a successful conclusion. Such a loss of patent protection would have a material adverse impact on our business. We have licensed our rights to setmelanotide from Ipsen Pharma SAS, or Ipsen. The off-label promotion of medicinal products is prohibited in the EU. We may be subject to federal and state healthcare and privacy laws and regulations. Our quarterly operating results may fluctuate significantly. As of December 31, 2020, we had 44,235,903 shares of common stock outstanding.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1649904/000155837021002121/0001558370-21-002121.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 40.00/100

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 130228
A - OSAIC HOLDINGS, INC. 2023-06-30 249
China Universal Asset Management Co., Ltd. 2023-06-30 745
MetLife Investment Management, LLC 2022-03-31 24442

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2023-02-28 32252 Long
Fidelity Commonwealth Trust 2023-02-28 12886 Long
Fidelity Concord Street Trust 2023-02-28 227121 Long
SPDR SERIES TRUST 2022-12-31 2957461 Long
SPDR INDEX SHARES FUNDS 2022-12-31 1732 Long


CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1636385 Smith Hunter C 2023-02-14 SALE Accept Accept Accept Accept
1909855 Shulman Joseph 2023-02-14 SALE Accept 0 0 0
1801372 Chien Jennifer 2023-02-14 SALE Accept 0 0 0
1774702 Mazabraud Yann 2023-02-09 SALE Accept 0 0 0
1873517 Cramer Pamela J. 2023-02-09 SALE Accept Accept Accept Accept

Bollinger Bollinger Bands for RHYTHM PHARMACEUTICALS INC can provide the information where the market is moving based on price information.

RHYTHM PHARMACEUTICALS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns RHYTHM PHARMACEUTICALS INC.

On-Balance Volume information for RHYTHM PHARMACEUTICALS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for RHYTHM PHARMACEUTICALS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for RHYTHM PHARMACEUTICALS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for RHYTHM PHARMACEUTICALS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for RHYTHM PHARMACEUTICALS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for RHYTHM PHARMACEUTICALS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for RHYTHM PHARMACEUTICALS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-10-19 22.36 2023-09-23 15:32
2023-10-20 22.35 2023-09-23 15:32
2023-10-04 22.90 2023-09-23 15:32
2023-10-06 22.68 2023-09-23 15:32
2023-09-28 23.16 2023-09-23 15:32
2023-10-11 22.63 2023-09-23 15:32
2023-10-13 22.52 2023-09-23 15:32
2023-09-25 23.14 2023-09-23 15:32
2023-09-26 23.17 2023-09-23 15:32
2023-10-05 22.86 2023-09-23 15:32
2023-09-29 22.92 2023-09-23 15:32
2023-10-03 22.83 2023-09-23 15:32
2023-11-02 22.05 2023-09-23 15:32
2023-11-08 21.94 2023-09-23 15:32
2023-11-13 21.86 2023-09-23 15:32
2023-11-14 21.83 2023-09-23 15:32
2023-10-18 22.40 2023-09-23 15:32
2023-10-09 22.60 2023-09-23 15:32
2023-10-10 22.65 2023-09-23 15:32
2023-11-03 22.03 2023-09-23 15:32
2023-11-10 21.88 2023-09-23 15:32
2023-10-27 22.18 2023-09-23 15:32
2023-10-12 22.54 2023-09-23 15:32
2023-10-23 22.32 2023-09-23 15:32
2023-10-24 22.26 2023-09-23 15:32
2023-09-27 23.25 2023-09-23 15:32
2023-10-16 22.48 2023-09-23 15:32
2023-11-15 21.81 2023-09-23 15:32
2023-10-02 22.94 2023-09-23 15:32
2023-10-25 22.22 2023-09-23 15:32
2023-11-09 21.91 2023-09-23 15:32
2023-11-06 22.00 2023-09-23 15:32
2023-11-07 21.97 2023-09-23 15:32
2023-10-17 22.41 2023-09-23 15:32
2023-11-16 21.78 2023-09-23 15:32
2023-10-30 22.16 2023-09-23 15:32
2023-10-31 22.11 2023-09-23 15:32
2023-11-01 22.07 2023-09-23 15:32
2023-10-26 22.20 2023-09-23 15:32
2023-11-17 21.75 2023-09-23 15:32

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.